Aileron Therapeutics Inc. (NASDAQ: ALRN)
$3.00
-0.1800 ( -5.66% ) 95.8K
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
Market Data
Open
$3.00
Previous close
$3.18
Volume
95.8K
Market cap
$64.41M
Day range
$2.83 - $3.26
52 week range
$1.01 - $7.42
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 4 | Jan 29, 2024 |
ars | Annual reports | 1 | Jan 29, 2024 |
8-k | 8K-related | 14 | Jan 29, 2024 |
8-k | 8K-related | 17 | Jan 25, 2024 |
pre | Proxies and info statements | 4 | Jan 19, 2024 |
8-k/a | 8K-related | 16 | Jan 11, 2024 |
8-k | 8K-related | 12 | Jan 10, 2024 |
4 | Insider transactions | 1 | Dec 18, 2023 |
4 | Insider transactions | 1 | Nov 21, 2023 |
3 | Insider transactions | 2 | Nov 02, 2023 |